Movement Disorders (revue) - Curation (Ncbi)

Index « Keywords » - entrée « Indoles (therapeutic use) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Indoles (pharmacology) < Indoles (therapeutic use) < Indonesia (epidemiology)  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 39.
[0-20] [0 - 20][0 - 39][20-38][20-40]
Ident.Authors (with country if any)Title
000113 (1999) W J Weiner [États-Unis]The initial treatment of Parkinson's disease should begin with levodopa.
000114 (1999) J L Montastruc [France] ; O. Rascol ; J M SenardTreatment of Parkinson's disease should begin with a dopamine agonist.
000148 (1999) N. Gálvez-Jiménez ; T. KhanRopinirole and restless legs syndrome.
000217 (2000) C W Olanow [États-Unis] ; A H Schapira ; T. RothWaking up to sleep episodes in Parkinson's disease.
000712 (2002) Paul Morrish [Royaume-Uni]Is it time to abandon functional imaging in the study of neuroprotection?
000875 (2002) DA agonists -- non-ergot derivatives: ropinirole: management of Parkinson's disease.
000B11 (2003) P K MorrishREAL and CALM: what have we learned?
000B35 (1992) B. Gomez-Mancilla [Canada] ; R. Boucher ; P J BédardEffect of LY 171555 and CY 208-243 on tremor suppression in the MPTP monkey model of parkinsonism.
000C40 (2003) Padraig O'Suilleabhain [États-Unis] ; Cole GillerRapidly progressive parkinsonism in a self-reported user of ecstasy and other drugs.
000F20 (1992) M. Emre [Suisse] ; U K Rinne ; A. Rascol ; A. Lees ; Yves Agid [France] ; X. LatasteEffects of a selective partial D1 agonist, CY 208-243, in de novo patients with Parkinson disease.
000F82 (2004) Yvonne Körner [Allemagne] ; Charlotte Meindorfner ; Jens Carsten Möller ; Karin Stiasny-Kolster ; Doris Haja ; Werner Cassel ; Wolfgang Hermann Oertel ; Hans-Peter KrügerPredictors of sudden onset of sleep in Parkinson's disease.
001001 (2004) William Bara-Jimenez [États-Unis] ; Tzvetelina Dimitrova ; Abdulah Sherzai ; Antonella Favit ; M M Mouradian ; Thomas N. ChaseEffect of monoamine reuptake inhibitor NS 2330 in advanced Parkinson's disease.
001025 (2004) Arthur S. Walters [États-Unis] ; William G. Ondo ; Tilman Dreykluft ; Ron Grunstein ; Daniel Lee ; Kapil SethiRopinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study.
001154 (2005) Robert M. Silva [États-Unis] ; Chia-Yi Kuan ; Pasko Rakic ; Robert E. BurkeMixed lineage kinase-c-jun N-terminal kinase signaling pathway: a new therapeutic target in Parkinson's disease.
001217 (2005) Christopher G. Goetz [États-Unis] ; Werner Poewe [Autriche] ; Olivier Rascol ; Cristina SampaioEvidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004.
001678 (2006) Anette Schrag [Royaume-Uni] ; Cristina Sampaio ; Nicholas Counsell ; Werner Poewe [Autriche]Minimal clinically important change on the unified Parkinson's disease rating scale.
001798 (2006) Jacques Montplaisir [Canada] ; Jeff Karrasch ; Jean Haan ; Dieter VolcRopinirole is effective in the long-term management of restless legs syndrome: a randomized controlled trial.
001857 (2006) Michael P. Hill [Royaume-Uni] ; Paula Ravenscroft ; Steven G. Mcguire ; Jonathan M. Brotchie ; Alan R. Crossman ; Catherine Rochat ; Mark J. MillanAntiparkinsonian effects of the novel D3/D2 dopamine receptor agonist, S32504, in MPTP-lesioned marmosets: Mediation by D2, not D3, dopamine receptors.
001949 (2007) Susann Junghanns [Allemagne] ; Joerg T. Fuhrmann ; Gregor Simonis ; Christian Oelwein ; Rainer Koch ; Ruth H. Strasser ; Heinz Reichmann ; Alexander StorchValvular heart disease in Parkinson's disease patients treated with dopamine agonists: a reader-blinded monocenter echocardiography study.
001955 (2007) Paolo Barone [Italie] ; Janice Lamb ; Amanda Ellis ; Zoe ClarkeSumanirole versus placebo or ropinirole for the adjunctive treatment of patients with advanced Parkinson's disease.
001B12 (2007) Carlos Singer [États-Unis] ; Janice Lamb ; Amanda Ellis ; Gary LaytonA comparison of sumanirole versus placebo or ropinirole for the treatment of patients with early Parkinson's disease.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Indoles (therapeutic use)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Indoles (therapeutic use)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Indoles (therapeutic use)
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024